Friday 6-20-2014 Gilead Sciences (GILD) $GILD opened at

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday 6-20-2014 Gilead Sciences (GILD) $GILD opened at 80.14 hitting the high price of 81.55 and a day low of 79.68 with a total volume of 17,946,359. GILD had a previous close of 79.78 and has been seeing an average volume of 10,486,800.

Overall Average: 32% Buy

Recent stock forum discussions about GILD http://investorshangout.com/search?q=GILD&...mp;yt0=Go!

Final Glance: Biotechnology companies
AP - Fri Jun 20, 5:05PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading: (full story)

Is Gilead Sciences, Inc. Destined for Greatness?
Alex Planes, The Motley Fool - Motley Fool - Fri Jun 20, 5:00PM CDT
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable market-beating gains, with robust and improving financial metrics that support strong price... (full story)

AstraZeneca's Naloxegol Data Published - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 5:00PM CDT
AstraZeneca (AZN) announced that data related to its opioid-induced constipation candidate, naloxegol, was published in the New England Journal of Medicine. (full story)

Alnylam-TAP Collaborate for AAT Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 3:45PM CDT
Alnylam Pharmaceuticals (ALNY) inked a collaboration deal with TAP for the continued development of ALN-AAT. (full story)

OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 2:50PM CDT
OncoMed Pharmaceuticals Inc. (OMED) recently suffered another setback when the FDA had placed a partial clinical hold on phase I clinical trials of another pipeline candidate, OMP-54F28. (full story)

Merge Healthcare: Updated Research Report - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 1:55PM CDT
On Jun 20, 2014, we issued an updated research report on Merge Healthcare Incorporated (MRGE). (full story)

Illumina: Updated Research Report - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 1:30PM CDT
On Jun 20, 2014, we issued an updated research report on life sciences company Illumina Inc. (ILMN). (full story)

Midday Glance: Biotechnology companies
AP - Fri Jun 20, 12:26PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.: (full story)

Achillion Could Win Idenix's Mystery Suitor: Analyst
at Investor's Business Daily - Fri Jun 20, 11:44AM CDT
Hot biotech stock Achillion Pharmaceuticals (ACHN) was up 2%, near 8.20, in midday trading in the stock market today after an analyst found more support for its prospects as a buyout candidate. R. W. Baird's Brian Skorney noted that Merck's (MRK)... (full story)

Better Stock Today Challenge: Gilead vs. DistributionNow
David Williamson and Joel South, The Motley Fool - Motley Fool - Fri Jun 20, 11:40AM CDT
In the spirit of World Cup competition, we're holding our own tournament in search of the Better Stock Today. We're pitting 32 companies against each other and you, the reader, will determine the winner. Today it's the round of 16, and   Gilead  ... (full story)

Celgene Rises on Yet Another Stock Split - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 10:30AM CDT
Shares of Gelgene (CELG) gained following the approval of a stock split. (full story)

Gilead Sciences (GILD) Crosses Pivot Point Resistance at $80.56
Comtex SmarTrend(R) - Fri Jun 20, 10:12AM CDT
Shares of Gilead Sciences (NASDAQ:GILD) have bullishly opened above the pivot of $79.72 today and have reached the first resistance level of $80.56. Should the shares continue to rise, the resistance pivots of $81.34 and $82.96 will be of interest. (full story)

Cubist Gets Priority Review from FDA for Antibiotic Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 10:00AM CDT
The FDA will review Cubist's (CBST) ceftolozane/tazobactam on a priority basis . (full story)

Early Glance: Biotechnology companies
AP - Fri Jun 20, 9:35AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.: (full story)

'Mad Money' Lightning Round: Buy, Buy, Buy Stryker
at The Street - Fri Jun 20, 5:00AM CDT
Cramer prefers Celgene over Gilead Sciences, Palo Alto Networks over OSI Systems and is discouraged by IBM. (full story)

Jim Cramer's 'Mad Money' Recap: Management Matters, Not the Fed
at The Street - Thu Jun 19, 6:57PM CDT
People obsessed with the Fed have kept you out of the market, Cramer said, and the Fed's bond buyback tapering is simply not having an impact. (full story)

Protalix Drug in Phase IIa Study for Gaucher Disease - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 5:15PM CDT
Protalix BioTherapeutics, Inc. (PLX) has enrolled the first patient in a phase IIa study on PRX-112 (oral GCD) for the treatment of Gaucher disease. (full story)

BioLineRx to Commence BL-8040 Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 5:10PM CDT
BioLineRx Ltd. (BLRX) announced that the Israeli Ministry of Health informed the company that it can start a phase I study on its oncology candidate, BL-8040. (full story)

Valeant Launches Hostile Bid for Allergan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 4:50PM CDT
Valeant Pharmaceuticals International, Inc. (VRX) announced that it has commenced an exchange offer for the common stock of Allergan, Inc (AGN). (full story)

Gilead Sciences Inc. (GILD) Stock Research Links

GILD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rural Hospitals Face Shaky Future; Warbird RCM Steps In

Updated Category News Views 6

Revamping Revenue Cycle Management for Rural Healthcare In a world that's increasingly teetering on the delicate tightrope of balance sheets, Warbird Healthcare Advisors is stepping into the ring with fists up, ready to fight for rural hospitals. Introducing their latest venture, Warbird RCM Partners, they're honing in on revenue cycle management and billing services to...

Continue Reading
Got Electric Expands to Coeburn, Strengthening Infrastructure

Updated Category News Views 4

You ever get tired of hearing the same old corporate spiel? Well, here's something real—Got Electric just opened a new office in Coeburn, Virginia, and it ain't just another pin on the map. It’s a move with some teeth, beefing up their ability to handle the electrical needs of Virginia, Tennessee, and North Carolina. A strategic play that’s got some serious regional...

Continue Reading
Italian Excellence: NYC Celebrates Innovators and Icons

Updated Category News Views 41

The Fusion of Italian Artistry and Innovation Imagine blending business savvy with a touch of culture and ethics. That's the spirit of the 9th Business Care International Award, which is gearing up to hit New York City's grand stage come November 18-19. This ain't just about pats on the back; it's a recognition of those who push Italian excellence across oceans and into...

Continue Reading
Duni Group Faces Ups and Downs in Q3 2026

Updated Category News Views 2

Navigating Choppy Waters: Duni's Third Quarter 2026 Alright, folks, let's dive into the latest from Duni Group—a company feeling the pinch but pushing through with some resilience. The third quarter 2026 report has just landed, and while some numbers are headed up, plenty are a bit of a gut punch. This isn't a crisis, but it's no smooth sailing either. Let's cut through...

Continue Reading
Vinitaly.USA 2026: Italian Wine Takes Manhattan

Updated Category News Views 11

A Two-Day Wine Extravaganza Hits New York If Italian wine was a stock, the Vinitaly.USA 2026 gathering in New York would be a rallying cry to double down. October 26-27 is set to be a whirl of handshakes and clinking glasses at Pier 36, all under the grand vision of beefing up Italy's hold on the U.S. wine market. As the compass points to growing opportunities, one can't...

Continue Reading
Hyperliquid Reports Q3 2026 Results with Webcast Insights

Updated Category News Views 13

Unlocking Hyperliquid’s Third Quarter Performance It's time to grab your investing gear because Hyperliquid Strategies Inc is ready to spill the beans on their Q3 2026 performance. The digital asset treasury focused on the hyperventilating HYPE token—fined-tuned to serve US and institutional investors—is broadcasting a live webcast on November 5, 2026. Mark your...

Continue Reading
Victor Care Networks Explores Transformative Mental Health

Updated Category News Views 4

Connections at the Core of Care Victor Care Network is stepping into the spotlight with a feature on "All Access hosted by Andy Garcia," putting human relationships front and center in mental health support. This ain't just another run-of-the-mill initiative—it’s a deep dive into the bonds that help people when the chips are down. So, what's it all about? Helping...

Continue Reading
Basic Invite's Holiday Card Service Offers Saving Time

Updated Category News Views 6

Getting the Cards Out: Maneuvering the Holiday Hustle Alright, let's dive into the madness that is holiday card season. Could be a logistical nightmare or a nostalgic tradition, depending on your cup of tea. Basic Invite here is trying to cut through the chaos by bumping deadlines and offering some straight-out-the-gate mailing options. If you play your cards right—pun...

Continue Reading
Gala Spotlights Veterans' Mental Health Support

Updated Category News Views 11

Champions for Veterans Honored at Headstrong Gala If you ever wondered who stands in the trenches alongside veterans facing mental health battles, this year's Headstrong Gala offered a crystal-clear answer. Held on October 16 at Pier Sixty in New York City, this shiindig wasn’t just about schmoozing over canapés. It was about celebrating the grit and guts of those...

Continue Reading
Bybit's USD1 Program Extends with 27M WLFI Reward Pot

Updated Category News Views 2

Bybit Extends USD1 Hold & Earn Program Man, when it comes to dangling a carrot, Bybit seems to know just the right length of stick to use. For those riding the crypto wave, they're reevaluating the worth of holding onto their digital coins, especially now that Bybit has renewed its USD1 Hold & Earn program. This isn't just a token gesture—it's a whopping 27 million WLFI...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil's Current Account: Insights Into Economic Trends

Updated Category News Views 518

Brazil's Economic Landscape and Current Account Insights Brazil's economic situation has taken a notable turn recently, with an evident shift in its current account balance. As reported by the central bank, the current account deficit reached an alarming **2.55% of the gross domestic product (GDP)** by the end of 2024. This figure reflects a **significant increase**...

Continue Reading
Exciting New Casting Opportunities for Actors in Los Angeles

Updated Category News Views 231

Fresh Casting Calls Available for Los Angeles Actors Los Angeles has always been the hub for aspiring actors looking for exciting opportunities in the entertainment industry. As the demand for talent increases, various casting calls have emerged that cater to both seasoned professionals and newcomers alike. This becomes particularly significant as Casting Networks...

Continue Reading
Key Upgrades in the Market: Insights into Booking Holdings

Updated Category News Views 163

Recent Analyst Upgrades and Market Insights In the bustling world of finance, analyst recommendations can significantly influence stock performance. Recently, several top Wall Street analysts have adjusted their positions regarding prominent companies. Let's delve into the key upgrades and what they mean for investors looking to navigate the market. Flutter Entertainment...

Continue Reading
Alex Karp Discusses Palantir's Commitment to Risk and Growth

Updated Category News Views 222

Palantir Technologies Inc. Stands Apart in Corporate Culture Palantir Technologies Inc. (NASDAQ: PLTR) is making waves in the tech industry with its progressive stance on corporate responsibility. CEO Alex Karp recently expressed the belief that many companies seeking bailouts often find themselves in dire straits—a scenario Palantir actively avoids. Karp's Views on...

Continue Reading
Smart Care Solutions Welcomes New CEO James Mylett

Updated Category News Views 850

Smart Care Solutions Welcomes New CEO Smart Care Solutions is making headlines with the exciting announcement of James Mylett as their new Chief Executive Officer. Mr. Mylett's expertise and leadership will guide the company as it embarks on its next growth phase. He takes on this role after serving as Senior Vice President of Digital Buildings at a prominent firm and has...

Continue Reading
le>